Bile acid diarrhoea research hub

Efficacy and safety of a novel dual pH-dependent delayed-release ColeseveLam for the trEatment of bile Acid diarrhoea: a Randomized, double-blind, parallel-group, placebo-controlled clinical trial - CLEAR

This study, called CLEAR, is testing a new form of Colesevelam. This medicine is for people with bile acid diarrhoea (BAD). Researchers want to see if it's safe and helps reduce symptoms in people aged 18 and over.